English

RIBI IMMUNOCHEM RESEARCH INC

EDGAR

Quarterly report (10-Q) · filed 1999-08-11

18 filing records in this dataset, filed from 1995-05-10 to 1999-08-11. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

1.56 million USD

1999-06-30 · USD

Exact inputs and evidence

Revenue: 1555000 USD Source

Net margin

-96.66%

1999-06-30 · %

Exact inputs and evidence

Net Income: -1503000 USD Source
Revenue: 1555000 USD Source

Operating cash flow

-1.16 million USD

1999-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: -1769000 USD Source
Operating Cash Flow: -608000 USD Source

Free cash flow

-1.35 million USD

1999-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: -1769000 USD Source
Operating Cash Flow: -608000 USD Source
Capital Expenditure: 547000 USD Source
Capital Expenditure: 358000 USD Source

Cash and cash equivalents: 95 thousand USD 1999-06-30 Source
Exact value

95000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

6.12 million USD

1998-07-01 – 1999-06-30

Exact inputs and evidence

Revenue: 1416000 USD · 1998-07-01 – 1998-09-30 Source
Revenue: 6123000 USD · 1998-01-01 – 1998-12-31 Source
Revenue: 4587000 USD · 1998-01-01 – 1998-09-30 Source
Revenue: 1613000 USD · 1999-01-01 – 1999-03-31 Source
Revenue: 1555000 USD · 1999-04-01 – 1999-06-30 Source

Net income

-7.01 million USD

1998-07-01 – 1999-06-30

Exact inputs and evidence

Net income: -1767000 USD · 1998-07-01 – 1998-09-30 Source
Net income: -7633000 USD · 1998-01-01 – 1998-12-31 Source
Net income: -5485000 USD · 1998-01-01 – 1998-09-30 Source
Net income: -1593000 USD · 1999-01-01 – 1999-03-31 Source
Net income: -1503000 USD · 1999-04-01 – 1999-06-30 Source

Operating cash flow

-5.71 million USD

1998-07-01 – 1999-06-30

Exact inputs and evidence

Operating cash flow: -2985000 USD · 1998-01-01 – 1998-09-30 Source
Operating cash flow: -1030000 USD · 1998-01-01 – 1998-06-30 Source
Operating cash flow: -4966000 USD · 1998-01-01 – 1998-12-31 Source
Operating cash flow: -2985000 USD · 1998-01-01 – 1998-09-30 Source
Operating cash flow: -608000 USD · 1999-01-01 – 1999-03-31 Source
Operating cash flow: -1769000 USD · 1999-01-01 – 1999-06-30 Source
Operating cash flow: -608000 USD · 1999-01-01 – 1999-03-31 Source

Capital expenditure

1.23 million USD

1998-07-01 – 1999-06-30

Exact inputs and evidence

Capital expenditure: 1026000 USD · 1998-01-01 – 1998-09-30 Source
Capital expenditure: 600000 USD · 1998-01-01 – 1998-06-30 Source
Capital expenditure: 1280000 USD · 1998-01-01 – 1998-12-31 Source
Capital expenditure: 1026000 USD · 1998-01-01 – 1998-09-30 Source
Capital expenditure: 358000 USD · 1999-01-01 – 1999-03-31 Source
Capital expenditure: 547000 USD · 1999-01-01 – 1999-06-30 Source
Capital expenditure: 358000 USD · 1999-01-01 – 1999-03-31 Source

Free cash flow

-6.93 million USD

1998-07-01 – 1999-06-30

Exact inputs and evidence

Operating cash flow: -2985000 USD · 1998-01-01 – 1998-09-30 Source
Operating cash flow: -1030000 USD · 1998-01-01 – 1998-06-30 Source
Operating cash flow: -4966000 USD · 1998-01-01 – 1998-12-31 Source
Operating cash flow: -2985000 USD · 1998-01-01 – 1998-09-30 Source
Operating cash flow: -608000 USD · 1999-01-01 – 1999-03-31 Source
Operating cash flow: -1769000 USD · 1999-01-01 – 1999-06-30 Source
Operating cash flow: -608000 USD · 1999-01-01 – 1999-03-31 Source
Capital expenditure: 1026000 USD · 1998-01-01 – 1998-09-30 Source
Capital expenditure: 600000 USD · 1998-01-01 – 1998-06-30 Source
Capital expenditure: 1280000 USD · 1998-01-01 – 1998-12-31 Source
Capital expenditure: 1026000 USD · 1998-01-01 – 1998-09-30 Source
Capital expenditure: 358000 USD · 1999-01-01 – 1999-03-31 Source
Capital expenditure: 547000 USD · 1999-01-01 – 1999-06-30 Source
Capital expenditure: 358000 USD · 1999-01-01 – 1999-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 1999-08-11.

Financial data available through: 1998-12-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 1998-12-31
operating income: No compatible figures in this window
Net income: 6 of 11 periods available· newest 1998-12-31
Operating cash flow: 6 of 11 periods available· newest 1998-12-31
Capital expenditure: 6 of 11 periods available· newest 1998-12-31
Total assets: 5 of 11 periods available· newest 1998-12-31
liabilities: No compatible figures in this window
Current assets: 5 of 11 periods available· newest 1998-12-31
Current liabilities: 5 of 11 periods available· newest 1998-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 1998-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-6.2%

Prior period

USD 6.53 million

1997-01-01 – 1997-12-31
Current period

USD 6.12 million

1998-01-01 – 1998-12-31

Exact inputs and evidence

6123000 − 6530000 = -407000 USD

6530000 USD · 1997-01-01 – 1997-12-31
Inspect prior input Prior source
6123000 USD · 1998-01-01 – 1998-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · RIBI IMMUNOCHEM RESEARCH INC · 1998-12-31 RIBI IMMUNOCHEM RESEARCH INC (edgar:352331) Year-over-year change in Revenue: -407000 USD Concept: fundies:Revenue Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-04T22:07:39Z Snapshot: 669e9a0e4271fc6032ff2f3aa362b5c3b3d8dd818585e8617206c9952e035aee Dimensions: Consolidated View: https://fundies.io/companies/edgar/352331?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 6123000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352331/0000352331-99-000003.txt#1941 Input fundies:Revenue: 6530000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352331/0000352331-99-000003.txt#1941
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 1.22 million

Prior period

−USD 6.42 million

1997-01-01 – 1997-12-31
Current period

−USD 7.63 million

1998-01-01 – 1998-12-31

Exact inputs and evidence

-7633000 − -6417000 = -1216000 USD

-6417000 USD · 1997-01-01 – 1997-12-31
Inspect prior input Prior source
-7633000 USD · 1998-01-01 – 1998-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · RIBI IMMUNOCHEM RESEARCH INC · 1998-12-31 RIBI IMMUNOCHEM RESEARCH INC (edgar:352331) Year-over-year change in Net income: -1216000 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-04T22:07:39Z Snapshot: 669e9a0e4271fc6032ff2f3aa362b5c3b3d8dd818585e8617206c9952e035aee Dimensions: Consolidated View: https://fundies.io/companies/edgar/352331?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -7633000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352331/0000352331-99-000003.txt#2098 Input fundies:NetIncome: -6417000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352331/0000352331-99-000003.txt#2098
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 237,000

Prior period

−USD 5.2 million

1997-01-01 – 1997-12-31
Current period

−USD 4.97 million

1998-01-01 – 1998-12-31

Exact inputs and evidence

-4966000 − -5203000 = 237000 USD

-5203000 USD · 1997-01-01 – 1997-12-31
Inspect prior input Prior source
-4966000 USD · 1998-01-01 – 1998-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · RIBI IMMUNOCHEM RESEARCH INC · 1998-12-31 RIBI IMMUNOCHEM RESEARCH INC (edgar:352331) Year-over-year change in Operating cash flow: 237000 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-04T22:07:39Z Snapshot: 669e9a0e4271fc6032ff2f3aa362b5c3b3d8dd818585e8617206c9952e035aee Dimensions: Consolidated View: https://fundies.io/companies/edgar/352331?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -4966000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352331/0000352331-99-000003.txt#2117 Input fundies:OperatingCashFlow: -5203000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352331/0000352331-99-000003.txt#2117
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+60.8%

Prior period

USD 796,000

1997-01-01 – 1997-12-31
Current period

USD 1.28 million

1998-01-01 – 1998-12-31

Exact inputs and evidence

1280000 − 796000 = 484000 USD

796000 USD · 1997-01-01 – 1997-12-31
Inspect prior input Prior source
1280000 USD · 1998-01-01 – 1998-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · RIBI IMMUNOCHEM RESEARCH INC · 1998-12-31 RIBI IMMUNOCHEM RESEARCH INC (edgar:352331) Year-over-year change in Capital expenditure: 484000 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-04T22:07:39Z Snapshot: 669e9a0e4271fc6032ff2f3aa362b5c3b3d8dd818585e8617206c9952e035aee Dimensions: Consolidated View: https://fundies.io/companies/edgar/352331?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 1280000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352331/0000352331-99-000003.txt#2121 Input fundies:CapitalExpenditure: 796000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352331/0000352331-99-000003.txt#2121
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

1998 1998-01-01 – 1998-12-31

Revenue USD 6.12 million 100% of revenue
Operating costs Derived Unavailable An input is unavailable.
Operating income Unavailable An input is unavailable.
Tax, interest and other Derived Unavailable An input is unavailable.
Net income −USD 7.63 million −125% of revenue

Cash

Operating cash flow −USD 4.97 million −81% of revenue
Capital expenditure USD 1.28 million 21% of revenue
Free cash flow Derived −USD 6.25 million −102% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1993 Not shown: operating income or net income is not reported.
1994 Not shown: operating income or net income is not reported.
1995 Not shown: operating income or net income is not reported.
1996 Not shown: operating income or net income is not reported.
1997 Not shown: operating income or net income is not reported.
1998 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1993 1993-01-01 – 1993-12-31	3162000	Unavailable	Unavailable	Unavailable	-3684000	-4111000 Derived	Source 1993-01-01 – 1993-12-31: 3162000 USD Inspect Revenue Open source 1993-01-01 – 1993-12-31: -3684000 USD Inspect Net Income Open source 1993-01-01 – 1993-12-31: -3293000 USD Inspect Operating Cash Flow Open source 1993-01-01 – 1993-12-31: 818000 USD Inspect Capital Expenditure Open source
1994 1994-01-01 – 1994-12-31	4554000	Unavailable	Unavailable	Unavailable	-3790000	-10052000 Derived	Source 1994-01-01 – 1994-12-31: 4554000 USD Inspect Revenue Open source 1994-01-01 – 1994-12-31: -3790000 USD Inspect Net Income Open source 1994-01-01 – 1994-12-31: -3426000 USD Inspect Operating Cash Flow Open source 1994-01-01 – 1994-12-31: 6626000 USD Inspect Capital Expenditure Open source
1995 1995-01-01 – 1995-12-31	4023000	Unavailable	Unavailable	Unavailable	-5317000	-6891000 Derived	Source 1995-01-01 – 1995-12-31: 4023000 USD Inspect Revenue Open source 1995-01-01 – 1995-12-31: -5317000 USD Inspect Net Income Open source 1995-01-01 – 1995-12-31: -5416000 USD Inspect Operating Cash Flow Open source 1995-01-01 – 1995-12-31: 1475000 USD Inspect Capital Expenditure Open source
1996 1996-01-01 – 1996-12-31	4623000	Unavailable	Unavailable	Unavailable	-5589000	-5617000 Derived	Source 1996-01-01 – 1996-12-31: 4623000 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: -5589000 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: -4693000 USD Inspect Operating Cash Flow Open source 1996-01-01 – 1996-12-31: 924000 USD Inspect Capital Expenditure Open source
1997 1997-01-01 – 1997-12-31	6530000	Unavailable	Unavailable	Unavailable	-6417000	-5999000 Derived	Source 1997-01-01 – 1997-12-31: 6530000 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: -6417000 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: -5203000 USD Inspect Operating Cash Flow Open source 1997-01-01 – 1997-12-31: 796000 USD Inspect Capital Expenditure Open source
1998 1998-01-01 – 1998-12-31	6123000	Unavailable	Unavailable	Unavailable	-7633000	-6246000 Derived	Source 1998-01-01 – 1998-12-31: 6123000 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -7633000 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: -4966000 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 1280000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 6.1M 1998

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19931993-12-31	Revenue	3162000	Revenue: 3162000 Open source
19941994-12-31	Revenue	4554000	Revenue: 4554000 Open source
19951995-12-31	Revenue	4023000	Revenue: 4023000 Open source
19961996-12-31	Revenue	4623000	Revenue: 4623000 Open source
19971997-12-31	Revenue	6530000	Revenue: 6530000 Open source
19981998-12-31	Revenue	6123000	Revenue: 6123000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-6.2% 1998

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19931993-12-31	Year over year	No prior comparable period	Revenue: 3162000 Open source
19941994-12-31	Year over year	44%	Revenue: 4554000 Open source Revenue: 3162000 Open source
19951995-12-31	Year over year	-11.7%	Revenue: 4023000 Open source Revenue: 4554000 Open source
19961996-12-31	Year over year	14.9%	Revenue: 4623000 Open source Revenue: 4023000 Open source
19971997-12-31	Year over year	41.3%	Revenue: 6530000 Open source Revenue: 4623000 Open source
19981998-12-31	Year over year	-6.2%	Revenue: 6123000 Open source Revenue: 6530000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Net margin -124.7% 1998

Free cash flow margin -102% 1998

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
1993-12-31	Operating margin	Not reported	Revenue: 3162000 Open source
1994-12-31	Operating margin	Not reported	Revenue: 4554000 Open source
1995-12-31	Operating margin	Not reported	Revenue: 4023000 Open source
1996-12-31	Operating margin	Not reported	Revenue: 4623000 Open source
1997-12-31	Operating margin	Not reported	Revenue: 6530000 Open source
1998-12-31	Operating margin	Not reported	Revenue: 6123000 Open source
19931993-12-31	Net margin	-116.5%	Net Income: -3684000 Open source Revenue: 3162000 Open source
19941994-12-31	Net margin	-83.2%	Net Income: -3790000 Open source Revenue: 4554000 Open source
19951995-12-31	Net margin	-132.2%	Net Income: -5317000 Open source Revenue: 4023000 Open source
19961996-12-31	Net margin	-120.9%	Net Income: -5589000 Open source Revenue: 4623000 Open source
19971997-12-31	Net margin	-98.3%	Net Income: -6417000 Open source Revenue: 6530000 Open source
19981998-12-31	Net margin	-124.7%	Net Income: -7633000 Open source Revenue: 6123000 Open source
19931993-12-31	Free cash flow margin	-130%	Revenue: 3162000 Open source Operating Cash Flow: -3293000 Open source Capital Expenditure: 818000 Open source
19941994-12-31	Free cash flow margin	-220.7%	Revenue: 4554000 Open source Operating Cash Flow: -3426000 Open source Capital Expenditure: 6626000 Open source
19951995-12-31	Free cash flow margin	-171.3%	Revenue: 4023000 Open source Operating Cash Flow: -5416000 Open source Capital Expenditure: 1475000 Open source
19961996-12-31	Free cash flow margin	-121.5%	Revenue: 4623000 Open source Operating Cash Flow: -4693000 Open source Capital Expenditure: 924000 Open source
19971997-12-31	Free cash flow margin	-91.9%	Revenue: 6530000 Open source Operating Cash Flow: -5203000 Open source Capital Expenditure: 796000 Open source
19981998-12-31	Free cash flow margin	-102%	Revenue: 6123000 Open source Operating Cash Flow: -4966000 Open source Capital Expenditure: 1280000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -5M 1998

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19931993-12-31	Operating cash flow	-3293000	Operating Cash Flow: -3293000 Open source
19941994-12-31	Operating cash flow	-3426000	Operating Cash Flow: -3426000 Open source
19951995-12-31	Operating cash flow	-5416000	Operating Cash Flow: -5416000 Open source
19961996-12-31	Operating cash flow	-4693000	Operating Cash Flow: -4693000 Open source
19971997-12-31	Operating cash flow	-5203000	Operating Cash Flow: -5203000 Open source
19981998-12-31	Operating cash flow	-4966000	Operating Cash Flow: -4966000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -6.2M 1998

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19931993-12-31	Free cash flow	-4111000	Operating Cash Flow: -3293000 Open source Capital Expenditure: 818000 Open source
19941994-12-31	Free cash flow	-10052000	Operating Cash Flow: -3426000 Open source Capital Expenditure: 6626000 Open source
19951995-12-31	Free cash flow	-6891000	Operating Cash Flow: -5416000 Open source Capital Expenditure: 1475000 Open source
19961996-12-31	Free cash flow	-5617000	Operating Cash Flow: -4693000 Open source Capital Expenditure: 924000 Open source
19971997-12-31	Free cash flow	-5999000	Operating Cash Flow: -5203000 Open source Capital Expenditure: 796000 Open source
19981998-12-31	Free cash flow	-6246000	Operating Cash Flow: -4966000 Open source Capital Expenditure: 1280000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1993-12-31	Liabilities / assets	Not reported	No source recorded
1994-12-31	Liabilities / assets	Not reported	Total Assets: 38824000 Open source
1995-12-31	Liabilities / assets	Not reported	Total Assets: 33911000 Open source
1996-12-31	Liabilities / assets	Not reported	Total Assets: 28298000 Open source
1997-12-31	Liabilities / assets	Not reported	Total Assets: 27770000 Open source
1998-12-31	Liabilities / assets	Not reported	Total Assets: 29828000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

3.77× 1998

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1993-12-31	Current assets / current liabilities	Not reported	No source recorded
19941994-12-31	Current assets / current liabilities	5.71×	Current Assets: 8483000 Open source Current Liabilities: 1486000 Open source
19951995-12-31	Current assets / current liabilities	9.36×	Current Assets: 13895000 Open source Current Liabilities: 1484000 Open source
19961996-12-31	Current assets / current liabilities	11.1×	Current Assets: 16105000 Open source Current Liabilities: 1451000 Open source
19971997-12-31	Current assets / current liabilities	6.68×	Current Assets: 15724000 Open source Current Liabilities: 2355000 Open source
19981998-12-31	Current assets / current liabilities	3.77×	Current Assets: 15925000 Open source Current Liabilities: 4228000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1993 1993-01-01 – 1993-12-31	−USD 3.68 million Exact value Exact value: -3684000 USD 1993-01-01 – 1993-12-31: -3684000 USD Inspect Net Income Open source Share or cite Citation for Net Income · RIBI IMMUNOCHEM RESEARCH INC · 1993-12-31 RIBI IMMUNOCHEM RESEARCH INC (edgar:352331) Net Income: -3684000 USD Concept: fundies:NetIncome Period: 1993-01-01 to 1993-12-31 Values: Latest reported Published: 2026-11-04T22:07:39Z Snapshot: 669e9a0e4271fc6032ff2f3aa362b5c3b3d8dd818585e8617206c9952e035aee Dimensions: Consolidated View: https://fundies.io/companies/edgar/352331/explain?concept=fundies%3ANetIncome&period=1993-12-31&surface=latest&period_type=duration&start=1993-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3684000 USD (1993-01-01 to 1993-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352331/0000352331-96-000005.txt#1887 The citation records this snapshot. The page link may show a newer release later.	−USD 3.29 million Exact value Exact value: -3293000 USD 1993-01-01 – 1993-12-31: -3293000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RIBI IMMUNOCHEM RESEARCH INC · 1993-12-31 RIBI IMMUNOCHEM RESEARCH INC (edgar:352331) Operating Cash Flow: -3293000 USD Concept: fundies:OperatingCashFlow Period: 1993-01-01 to 1993-12-31 Values: Latest reported Published: 2026-11-04T22:07:39Z Snapshot: 669e9a0e4271fc6032ff2f3aa362b5c3b3d8dd818585e8617206c9952e035aee Dimensions: Consolidated View: https://fundies.io/companies/edgar/352331/explain?concept=fundies%3AOperatingCashFlow&period=1993-12-31&surface=latest&period_type=duration&start=1993-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3293000 USD (1993-01-01 to 1993-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352331/0000352331-96-000005.txt#1910 The citation records this snapshot. The page link may show a newer release later.	USD 818,000 Exact value Exact value: 818000 USD 1993-01-01 – 1993-12-31: 818000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RIBI IMMUNOCHEM RESEARCH INC · 1993-12-31 RIBI IMMUNOCHEM RESEARCH INC (edgar:352331) Capital Expenditure: 818000 USD Concept: fundies:CapitalExpenditure Period: 1993-01-01 to 1993-12-31 Values: Latest reported Published: 2026-11-04T22:07:39Z Snapshot: 669e9a0e4271fc6032ff2f3aa362b5c3b3d8dd818585e8617206c9952e035aee Dimensions: Consolidated View: https://fundies.io/companies/edgar/352331/explain?concept=fundies%3ACapitalExpenditure&period=1993-12-31&surface=latest&period_type=duration&start=1993-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 818000 USD (1993-01-01 to 1993-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352331/0000352331-96-000005.txt#1914 The citation records this snapshot. The page link may show a newer release later.	−USD 4.11 million Calculation and evidence -3293000 − 818000 USD Exact free cash flow: -4111000 USD 1993-01-01 – 1993-12-31: -3293000 USD · Inspect Operating Cash Flow · Source 1993-01-01 – 1993-12-31: 818000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RIBI IMMUNOCHEM RESEARCH INC · 1993-12-31 RIBI IMMUNOCHEM RESEARCH INC (edgar:352331) Free cash flow: -4111000 USD Concept: free-cash-flow Period: 1993-01-01 to 1993-12-31 Values: Latest reported Published: 2026-11-04T22:07:39Z Snapshot: 669e9a0e4271fc6032ff2f3aa362b5c3b3d8dd818585e8617206c9952e035aee Dimensions: Consolidated View: https://fundies.io/companies/edgar/352331?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3293000 USD (1993-01-01 to 1993-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352331/0000352331-96-000005.txt#1910 Input fundies:CapitalExpenditure: 818000 USD (1993-01-01 to 1993-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352331/0000352331-96-000005.txt#1914 The citation records this snapshot. The page link may show a newer release later.
1994 1994-01-01 – 1994-12-31	−USD 3.79 million Exact value Exact value: -3790000 USD 1994-01-01 – 1994-12-31: -3790000 USD Inspect Net Income Open source Share or cite Citation for Net Income · RIBI IMMUNOCHEM RESEARCH INC · 1994-12-31 RIBI IMMUNOCHEM RESEARCH INC (edgar:352331) Net Income: -3790000 USD Concept: fundies:NetIncome Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-04T22:07:39Z Snapshot: 669e9a0e4271fc6032ff2f3aa362b5c3b3d8dd818585e8617206c9952e035aee Dimensions: Consolidated View: https://fundies.io/companies/edgar/352331/explain?concept=fundies%3ANetIncome&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3790000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352331/0000352331-97-000004.txt#1860 The citation records this snapshot. The page link may show a newer release later.	−USD 3.43 million Exact value Exact value: -3426000 USD 1994-01-01 – 1994-12-31: -3426000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RIBI IMMUNOCHEM RESEARCH INC · 1994-12-31 RIBI IMMUNOCHEM RESEARCH INC (edgar:352331) Operating Cash Flow: -3426000 USD Concept: fundies:OperatingCashFlow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-04T22:07:39Z Snapshot: 669e9a0e4271fc6032ff2f3aa362b5c3b3d8dd818585e8617206c9952e035aee Dimensions: Consolidated View: https://fundies.io/companies/edgar/352331/explain?concept=fundies%3AOperatingCashFlow&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3426000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352331/0000352331-97-000004.txt#1881 The citation records this snapshot. The page link may show a newer release later.	USD 6.63 million Exact value Exact value: 6626000 USD 1994-01-01 – 1994-12-31: 6626000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RIBI IMMUNOCHEM RESEARCH INC · 1994-12-31 RIBI IMMUNOCHEM RESEARCH INC (edgar:352331) Capital Expenditure: 6626000 USD Concept: fundies:CapitalExpenditure Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-04T22:07:39Z Snapshot: 669e9a0e4271fc6032ff2f3aa362b5c3b3d8dd818585e8617206c9952e035aee Dimensions: Consolidated View: https://fundies.io/companies/edgar/352331/explain?concept=fundies%3ACapitalExpenditure&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6626000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352331/0000352331-97-000004.txt#1885 The citation records this snapshot. The page link may show a newer release later.	−USD 10.05 million Calculation and evidence -3426000 − 6626000 USD Exact free cash flow: -10052000 USD 1994-01-01 – 1994-12-31: -3426000 USD · Inspect Operating Cash Flow · Source 1994-01-01 – 1994-12-31: 6626000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RIBI IMMUNOCHEM RESEARCH INC · 1994-12-31 RIBI IMMUNOCHEM RESEARCH INC (edgar:352331) Free cash flow: -10052000 USD Concept: free-cash-flow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-04T22:07:39Z Snapshot: 669e9a0e4271fc6032ff2f3aa362b5c3b3d8dd818585e8617206c9952e035aee Dimensions: Consolidated View: https://fundies.io/companies/edgar/352331?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3426000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352331/0000352331-97-000004.txt#1881 Input fundies:CapitalExpenditure: 6626000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352331/0000352331-97-000004.txt#1885 The citation records this snapshot. The page link may show a newer release later.
1995 1995-01-01 – 1995-12-31	−USD 5.32 million Exact value Exact value: -5317000 USD 1995-01-01 – 1995-12-31: -5317000 USD Inspect Net Income Open source Share or cite Citation for Net Income · RIBI IMMUNOCHEM RESEARCH INC · 1995-12-31 RIBI IMMUNOCHEM RESEARCH INC (edgar:352331) Net Income: -5317000 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-04T22:07:39Z Snapshot: 669e9a0e4271fc6032ff2f3aa362b5c3b3d8dd818585e8617206c9952e035aee Dimensions: Consolidated View: https://fundies.io/companies/edgar/352331/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5317000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352331/0000352331-98-000002.txt#1899 The citation records this snapshot. The page link may show a newer release later.	−USD 5.42 million Exact value Exact value: -5416000 USD 1995-01-01 – 1995-12-31: -5416000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RIBI IMMUNOCHEM RESEARCH INC · 1995-12-31 RIBI IMMUNOCHEM RESEARCH INC (edgar:352331) Operating Cash Flow: -5416000 USD Concept: fundies:OperatingCashFlow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-04T22:07:39Z Snapshot: 669e9a0e4271fc6032ff2f3aa362b5c3b3d8dd818585e8617206c9952e035aee Dimensions: Consolidated View: https://fundies.io/companies/edgar/352331/explain?concept=fundies%3AOperatingCashFlow&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5416000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352331/0000352331-98-000002.txt#1919 The citation records this snapshot. The page link may show a newer release later.	USD 1.48 million Exact value Exact value: 1475000 USD 1995-01-01 – 1995-12-31: 1475000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RIBI IMMUNOCHEM RESEARCH INC · 1995-12-31 RIBI IMMUNOCHEM RESEARCH INC (edgar:352331) Capital Expenditure: 1475000 USD Concept: fundies:CapitalExpenditure Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-04T22:07:39Z Snapshot: 669e9a0e4271fc6032ff2f3aa362b5c3b3d8dd818585e8617206c9952e035aee Dimensions: Consolidated View: https://fundies.io/companies/edgar/352331/explain?concept=fundies%3ACapitalExpenditure&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1475000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352331/0000352331-98-000002.txt#1923 The citation records this snapshot. The page link may show a newer release later.	−USD 6.89 million Calculation and evidence -5416000 − 1475000 USD Exact free cash flow: -6891000 USD 1995-01-01 – 1995-12-31: -5416000 USD · Inspect Operating Cash Flow · Source 1995-01-01 – 1995-12-31: 1475000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RIBI IMMUNOCHEM RESEARCH INC · 1995-12-31 RIBI IMMUNOCHEM RESEARCH INC (edgar:352331) Free cash flow: -6891000 USD Concept: free-cash-flow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-04T22:07:39Z Snapshot: 669e9a0e4271fc6032ff2f3aa362b5c3b3d8dd818585e8617206c9952e035aee Dimensions: Consolidated View: https://fundies.io/companies/edgar/352331?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5416000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352331/0000352331-98-000002.txt#1919 Input fundies:CapitalExpenditure: 1475000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352331/0000352331-98-000002.txt#1923 The citation records this snapshot. The page link may show a newer release later.
1996 1996-01-01 – 1996-12-31	−USD 5.59 million Exact value Exact value: -5589000 USD 1996-01-01 – 1996-12-31: -5589000 USD Inspect Net Income Open source Share or cite Citation for Net Income · RIBI IMMUNOCHEM RESEARCH INC · 1996-12-31 RIBI IMMUNOCHEM RESEARCH INC (edgar:352331) Net Income: -5589000 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-04T22:07:39Z Snapshot: 669e9a0e4271fc6032ff2f3aa362b5c3b3d8dd818585e8617206c9952e035aee Dimensions: Consolidated View: https://fundies.io/companies/edgar/352331/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5589000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352331/0000352331-99-000003.txt#2098 The citation records this snapshot. The page link may show a newer release later.	−USD 4.69 million Exact value Exact value: -4693000 USD 1996-01-01 – 1996-12-31: -4693000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RIBI IMMUNOCHEM RESEARCH INC · 1996-12-31 RIBI IMMUNOCHEM RESEARCH INC (edgar:352331) Operating Cash Flow: -4693000 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-04T22:07:39Z Snapshot: 669e9a0e4271fc6032ff2f3aa362b5c3b3d8dd818585e8617206c9952e035aee Dimensions: Consolidated View: https://fundies.io/companies/edgar/352331/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4693000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352331/0000352331-99-000003.txt#2117 The citation records this snapshot. The page link may show a newer release later.	USD 924,000 Exact value Exact value: 924000 USD 1996-01-01 – 1996-12-31: 924000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RIBI IMMUNOCHEM RESEARCH INC · 1996-12-31 RIBI IMMUNOCHEM RESEARCH INC (edgar:352331) Capital Expenditure: 924000 USD Concept: fundies:CapitalExpenditure Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-04T22:07:39Z Snapshot: 669e9a0e4271fc6032ff2f3aa362b5c3b3d8dd818585e8617206c9952e035aee Dimensions: Consolidated View: https://fundies.io/companies/edgar/352331/explain?concept=fundies%3ACapitalExpenditure&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 924000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352331/0000352331-99-000003.txt#2121 The citation records this snapshot. The page link may show a newer release later.	−USD 5.62 million Calculation and evidence -4693000 − 924000 USD Exact free cash flow: -5617000 USD 1996-01-01 – 1996-12-31: -4693000 USD · Inspect Operating Cash Flow · Source 1996-01-01 – 1996-12-31: 924000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RIBI IMMUNOCHEM RESEARCH INC · 1996-12-31 RIBI IMMUNOCHEM RESEARCH INC (edgar:352331) Free cash flow: -5617000 USD Concept: free-cash-flow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-04T22:07:39Z Snapshot: 669e9a0e4271fc6032ff2f3aa362b5c3b3d8dd818585e8617206c9952e035aee Dimensions: Consolidated View: https://fundies.io/companies/edgar/352331?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4693000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352331/0000352331-99-000003.txt#2117 Input fundies:CapitalExpenditure: 924000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352331/0000352331-99-000003.txt#2121 The citation records this snapshot. The page link may show a newer release later.
1997 1997-01-01 – 1997-12-31	−USD 6.42 million Exact value Exact value: -6417000 USD 1997-01-01 – 1997-12-31: -6417000 USD Inspect Net Income Open source Share or cite Citation for Net Income · RIBI IMMUNOCHEM RESEARCH INC · 1997-12-31 RIBI IMMUNOCHEM RESEARCH INC (edgar:352331) Net Income: -6417000 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-04T22:07:39Z Snapshot: 669e9a0e4271fc6032ff2f3aa362b5c3b3d8dd818585e8617206c9952e035aee Dimensions: Consolidated View: https://fundies.io/companies/edgar/352331/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6417000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352331/0000352331-99-000003.txt#2098 The citation records this snapshot. The page link may show a newer release later.	−USD 5.2 million Exact value Exact value: -5203000 USD 1997-01-01 – 1997-12-31: -5203000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RIBI IMMUNOCHEM RESEARCH INC · 1997-12-31 RIBI IMMUNOCHEM RESEARCH INC (edgar:352331) Operating Cash Flow: -5203000 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-04T22:07:39Z Snapshot: 669e9a0e4271fc6032ff2f3aa362b5c3b3d8dd818585e8617206c9952e035aee Dimensions: Consolidated View: https://fundies.io/companies/edgar/352331/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5203000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352331/0000352331-99-000003.txt#2117 The citation records this snapshot. The page link may show a newer release later.	USD 796,000 Exact value Exact value: 796000 USD 1997-01-01 – 1997-12-31: 796000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RIBI IMMUNOCHEM RESEARCH INC · 1997-12-31 RIBI IMMUNOCHEM RESEARCH INC (edgar:352331) Capital Expenditure: 796000 USD Concept: fundies:CapitalExpenditure Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-04T22:07:39Z Snapshot: 669e9a0e4271fc6032ff2f3aa362b5c3b3d8dd818585e8617206c9952e035aee Dimensions: Consolidated View: https://fundies.io/companies/edgar/352331/explain?concept=fundies%3ACapitalExpenditure&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 796000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352331/0000352331-99-000003.txt#2121 The citation records this snapshot. The page link may show a newer release later.	−USD 6 million Calculation and evidence -5203000 − 796000 USD Exact free cash flow: -5999000 USD 1997-01-01 – 1997-12-31: -5203000 USD · Inspect Operating Cash Flow · Source 1997-01-01 – 1997-12-31: 796000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RIBI IMMUNOCHEM RESEARCH INC · 1997-12-31 RIBI IMMUNOCHEM RESEARCH INC (edgar:352331) Free cash flow: -5999000 USD Concept: free-cash-flow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-04T22:07:39Z Snapshot: 669e9a0e4271fc6032ff2f3aa362b5c3b3d8dd818585e8617206c9952e035aee Dimensions: Consolidated View: https://fundies.io/companies/edgar/352331?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5203000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352331/0000352331-99-000003.txt#2117 Input fundies:CapitalExpenditure: 796000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352331/0000352331-99-000003.txt#2121 The citation records this snapshot. The page link may show a newer release later.
1998 1998-01-01 – 1998-12-31	−USD 7.63 million Exact value Exact value: -7633000 USD 1998-01-01 – 1998-12-31: -7633000 USD Inspect Net Income Open source Share or cite Citation for Net Income · RIBI IMMUNOCHEM RESEARCH INC · 1998-12-31 RIBI IMMUNOCHEM RESEARCH INC (edgar:352331) Net Income: -7633000 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-04T22:07:39Z Snapshot: 669e9a0e4271fc6032ff2f3aa362b5c3b3d8dd818585e8617206c9952e035aee Dimensions: Consolidated View: https://fundies.io/companies/edgar/352331/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7633000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352331/0000352331-99-000003.txt#2098 The citation records this snapshot. The page link may show a newer release later.	−USD 4.97 million Exact value Exact value: -4966000 USD 1998-01-01 – 1998-12-31: -4966000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RIBI IMMUNOCHEM RESEARCH INC · 1998-12-31 RIBI IMMUNOCHEM RESEARCH INC (edgar:352331) Operating Cash Flow: -4966000 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-04T22:07:39Z Snapshot: 669e9a0e4271fc6032ff2f3aa362b5c3b3d8dd818585e8617206c9952e035aee Dimensions: Consolidated View: https://fundies.io/companies/edgar/352331/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4966000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352331/0000352331-99-000003.txt#2117 The citation records this snapshot. The page link may show a newer release later.	USD 1.28 million Exact value Exact value: 1280000 USD 1998-01-01 – 1998-12-31: 1280000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RIBI IMMUNOCHEM RESEARCH INC · 1998-12-31 RIBI IMMUNOCHEM RESEARCH INC (edgar:352331) Capital Expenditure: 1280000 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-04T22:07:39Z Snapshot: 669e9a0e4271fc6032ff2f3aa362b5c3b3d8dd818585e8617206c9952e035aee Dimensions: Consolidated View: https://fundies.io/companies/edgar/352331/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1280000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352331/0000352331-99-000003.txt#2121 The citation records this snapshot. The page link may show a newer release later.	−USD 6.25 million Calculation and evidence -4966000 − 1280000 USD Exact free cash flow: -6246000 USD 1998-01-01 – 1998-12-31: -4966000 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 1280000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RIBI IMMUNOCHEM RESEARCH INC · 1998-12-31 RIBI IMMUNOCHEM RESEARCH INC (edgar:352331) Free cash flow: -6246000 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-04T22:07:39Z Snapshot: 669e9a0e4271fc6032ff2f3aa362b5c3b3d8dd818585e8617206c9952e035aee Dimensions: Consolidated View: https://fundies.io/companies/edgar/352331?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4966000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352331/0000352331-99-000003.txt#2117 Input fundies:CapitalExpenditure: 1280000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352331/0000352331-99-000003.txt#2121 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

18 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-04. Source filing dates and reporting periods are shown separately.

Identifiers: 0000352331, 352331, edgar:352331

RIBI IMMUNOCHEM RESEARCH INC

Latest quarter

Revenue

Net margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

1998 1998-01-01 – 1998-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation